Evidence map›Paper›PMID 33585234›Full record

ArticleFrontiers in oncology2020

RNA m

Lin Yang, Shuangling Wu, Chunhui Ma, Shuhui Song, Feng Jin, Yamei Niu, Wei-Min Tong

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in oncology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
0.9field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 16 citations in OpenAlex.

  1. Methylation marks breast cancer metastasis: The roles of mThe Journal of biological chemistry · 2026
    Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. IGF2BPs as novel mGenes & diseases · 2024
    Review
  8. Review
  9. Review
  10. Review
  11. m6A RNA Methylation Regulators Contribute to Predict and as a Therapy Target of Pulmonary Fibrosis.Evidence-based complementary and alternative medicine : eCAM · 2022
    Article
  12. Article
  13. The Key Role of RNA Modification in Breast Cancer.Frontiers in cell and developmental biology · 2022
    Review
  14. RNA mFrontiers in cell and developmental biology · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

Lin YangDepartment of Pathology, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences, Beijing, China.
Shuangling WuDepartment of Breast Surgery, The First Affiliated Hospital of China Medical University, Shenyang, China.
Chunhui MaDepartment of Pathology, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences, Beijing, China.
Shuhui SongChina National Center for Bioinformation, Beijing, China.
Feng JinDepartment of Breast Surgery, The First Affiliated Hospital of China Medical University, Shenyang, China.
Yamei NiuDepartment of Pathology, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences, Beijing, China.
Wei-Min TongDepartment of Pathology, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences, Beijing, China.
Peking Union Medical College Hospital · CNChina Medical University · CNChinese Academy of Medical Sciences & Peking Union Medical College · CNShanghai Center For Bioinformation Technology · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

RNA N

Indexed as

breast cancer subtypesgenomic regulationm6A regulatorsRNA methylationsubclassificationsurvival

Identifiers

PMID33585234
PMCPMC7878528
OpenAlexW3127719805

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.